Elevance Health Files 8-K on Financials

Ticker: ELV · Form: 8-K · Filed: 2025-01-23T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, results-of-operations

TL;DR

Elevance Health dropped its latest 8-K with financial updates. Check it out.

AI Summary

Elevance Health, Inc. filed an 8-K on January 23, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's performance. Elevance Health, formerly known as Anthem, Inc., is incorporated in Indiana and headquartered in Indianapolis.

Why It Matters

This 8-K filing provides investors with crucial updates on Elevance Health's financial performance and operational results, impacting investment decisions.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any unusual risks or events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Elevance Health, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.

When was this 8-K filed?

This 8-K was filed on January 23, 2025.

What are some of the former names of Elevance Health, Inc. mentioned in the filing?

The filing mentions former names including Anthem, Inc. and WELLPOINT, INC.

Where are Elevance Health, Inc.'s principal executive offices located?

Elevance Health, Inc.'s principal executive offices are located at 220 Virginia Ave, Indianapolis, IN 46204.

In which state is Elevance Health, Inc. incorporated?

Elevance Health, Inc. is incorporated in Indiana.

From the Filing

0001156039-25-000007.txt : 20250123 0001156039-25-000007.hdr.sgml : 20250123 20250123060324 ACCESSION NUMBER: 0001156039-25-000007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 20 CONFORMED PERIOD OF REPORT: 20250123 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250123 DATE AS OF CHANGE: 20250123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 25547521 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 8-K 1 elv-20250123.htm 8-K elv-20250123 FALSE 0001156039 0001156039 2025-01-23 2025-01-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 23, 2025 Date of Report (Date of earliest event reported) ___________________________________ Elevance Health, Inc. (Exact name of registrant as specified in its charter) ___________________________________ Indiana (State or other jurisdiction of incorporation or organization) 001-16751 (Commission File Number) 35-2145715 (I.R.S. Employer Identification Number) 220 Virginia Ave Indianapolis , IN 46204 (Address of principal executive offices and zip code) ( 833 ) 401-1577 (Registrant's telephone number, including area code) ________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark whether the registrant is an emerging growth company as defined Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 2.02 - Results of Operations and Financial Condition. On January 23, 2025, Elevance Health, Inc. issued a press release reporting its fourth quarter and full year 2024 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. None of the information furnished in Item 2.02 or Exhibit 99.1 hereto shall be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be

View on Read The Filing